Daniel M. Jones
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hepatology top 2%
- Hepatitis C virus research
Papers in
- Epidemiology 16
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Samuel Singer (1 shared paper)Daniel J. DeAngelo (1 shared paper)Sylvia A. Holden (1 shared paper)Elisabetta Mueller (1 shared paper)Lan Bo Chen (1 shared paper)Bruce M. Spiegelman (1 shared paper)Christopher D.�M. Fletcher (1 shared paper)Pasha Sarraf (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cell Reports (4 papers)Scientific Reports (3 papers)Blood (3 papers)Vaccine (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Daniel M. Jones
68 papers receiving 3.2k citations
Daniel M. Jones's Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 624
- Hepatology 363
- Genetics 399
- Cancer Research 563
- Infectious Diseases 614
Countries citing papers authored by Daniel M. Jones
This map shows the geographic impact of Daniel M. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Jones more than expected).
Fields of papers citing papers by Daniel M. Jones
This network shows the impact of papers produced by Daniel M. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Jones. The network helps show where Daniel M. Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel M. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Differentiation and reversal of malignant changes in colon cancer through PPARγ Hit paper breakdown → | 1998 | 865 |
| 2 | 2010 | 282 | |
| 3 | 2016 | 179 | |
| 4 | Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2 Hit paper breakdown → | 2022 | 158 |
| 5 | 2006 | 152 | |
| 6 | 2008 | 115 | |
| 7 | 2000 | 114 | |
| 8 | Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants Hit paper breakdown → | 2023 | 96 |
| 9 | 2013 | 94 | |
| 10 | 2009 | 94 | |
| 11 | 2010 | 87 | |
| 12 | 2006 | 82 | |
| 13 | 2017 | 69 | |
| 14 | 2015 | 56 | |
| 15 | 2014 | 55 | |
| 16 | 2013 | 54 | |
| 17 | 2009 | 50 | |
| 18 | 2021 | 50 | |
| 19 | 2016 | 49 | |
| 20 | 2024 | 35 |
About Daniel M. Jones
Daniel M. Jones is a scholar working on Molecular Biology, Epidemiology, Infectious Diseases, Hematology and Hepatology, having authored 71 papers that have together received 3.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). The work is most often cited by research in Hematology (624 citations), Hepatology (363 citations), Genetics (399 citations), Cancer Research (563 citations) and Infectious Diseases (614 citations). Daniel M. Jones has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Samuel Singer, Daniel J. DeAngelo, Sylvia A. Holden, Elisabetta Mueller, Lan Bo Chen, Bruce M. Spiegelman, Christopher D.�M. Fletcher, Pasha Sarraf, John McLauchlan and Hagop M. Kantarjian. Their work appears in journals such as Journal of Clinical Oncology, Cell Reports, Scientific Reports, Blood and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.